Vital Care 2026 Initials and SD Renewal vs ACASA Senior Care

Vital Care is the stronger opportunity right now, and it’s not especially close. The dimension that dominates here is budget. With an AUV north of $17M and an investment range that starts above $800K, these franchisees are operating at a scale where multi-module software spend isn’t a negotiation—it’s infrastructure. ACASA’s sub-$7M AUV and sub-$134K buildout cost signal leaner operators who will nickel-and-dime every SaaS line item. When you’re selling POS, marketing automation, and back-office, you want the customer who views a $2K/month stack as rounding error, not a board-level decision. Vital Care gives you that.

The TAM gap is equally decisive. With 143 franchised units versus 7, Vital Care offers an addressable base that can actually move your pipeline needle. ACASA’s 40% unit growth is impressive on a percentage basis, but it’s growth off a tiny denominator—adding three units a year doesn’t build a repeatable sales motion. The tradeoff you’re making is procurement friction. ACASA’s approved-supplier model means once you’re in, you’re locked; Vital Care’s standards-based model means you sell location by location with no central mandate. That’s real, but it’s a sales process problem, not a market-size problem. You can solve for decentralized buying with outbound muscle. You can’t solve for a TAM of seven.

Timing seals it. Vital Care’s FDD is current, 2026 fiscal, which signals an active, expanding system with fresh disclosure obligations—prime window for vendor evaluation. ACASA’s filing is marked DUE, meaning stale data and potentially distracted leadership. You don’t want to build a vertical beachhead on a brand that might not have its compliance house in order.

Verdict: Vital Care’s massive unit economics and 143-unit base outweigh ACASA’s procurement lock-in and growth rate; sell where the money is.